title: [Re-treatment guideline of ranibizumab (genetical recombination) in the maintenance phase].
authors.affiliation: Department of Ophthalmology, Shiga University of Medical Science, Japan.
authors.forename: Yasuo
authors.initials: Y
authors.lastname: Tano
authors.forename: Masahito
authors.initials: M
authors.lastname: Ohji
authors.forename: Tatsuro
authors.initials: T
authors.lastname: Ishibashi
authors.forename: Fumio
authors.initials: F
authors.lastname: Shiraga
authors.forename: Takashi
authors.initials: T
authors.lastname: Tokoro
authors.forename: Mitsuko
authors.initials: M
authors.lastname: Yuzawa
authors.forename: Nagahisa
authors.initials: N
authors.lastname: Yoshimura
mesh_terms: D000465:Algorithms; D000911:Antibodies, Monoclonal / Q000008:administration & dosage*; D061067:Antibodies, Monoclonal, Humanized; D006801:Humans; D008268:Macular Degeneration / Q000188:drug therapy*; D017410:Practice Guidelines as Topic; D000069579:Ranibizumab
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000069579:Ranibizumab